Sign in
Groups
Researchers
Funding
Results
Funding
Funder
:
INTERNATIONAL MYELOMA SOCIETY (IMS)
Scope
International (non-EU) (2)
2 funding
- 454,932€
data available since 2023
2024
Modeling, unraveling, and beating acquired resistance to BCMA and GPRC5D targeted agents in multiple myeloma.
euro
225,932.00
2023
Modeling, unraveling, and beating acquired resistance to BCMA and GPRC5D targeted agents in multiple myeloma
euro
229,000.00
Contact
Legal notice
Help
translate
en
arrow_drop_down
translate
en
arrow_drop_down
es
ca
eu
gl
fr
de